FDA Inspection 1191869 — Lonza AG
The FDA completed an inspection of Lonza AG on Nov 4, 2022 in Basel Town. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 4, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basel Town (Switzerland)